/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

D

David C. Chhieng

University of Washington(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

304

Papers

9.6K

Citations

53

h-index

158

i10-index

David C. Chhieng is an academic researcher from University of Washington. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Cervical Cancer and HPV Research & Thyroid Cancer Diagnosis and Treatment. The author has an h-index of 53, co-authored 259 publications.

Research Topics

Pancreatic and Hepatic Oncology Research Cervical Cancer and HPV Research Thyroid Cancer Diagnosis and Treatment Neuroendocrine Tumor Research Advances Salivary Gland Tumors Diagnosis and Treatment

Papers by this author

works

Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657

2012 · Journal of Clinical Oncology · 437 citations

https://doi.org/10.1200/jco.2011.39.2779

Laura J. Esserman Donald A. Berry Angela DeMichele Lisa A. Carey

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

2011 · Breast Cancer Research and Treatment · 356 citations

https://doi.org/10.1007/s10549-011-1895-2

Laura J. Esserman Donald A. Berry Maggie C.U. Cheang Christina Yau

Fine needle aspiration biopsy of liver – an update

2004 · World Journal of Surgical Oncology · 58 citations

https://doi.org/10.1186/1477-7819-2-5

David C. Chhieng

Using a Higher Cutoff for the Percentage of HER2+ Cells Decreases Interobserver Variability in the Interpretation of HER2 Immunohistochemical Analysis

2008 · American Journal of Clinical Pathology · 22 citations

https://doi.org/10.1309/ketm3hanluqhw7yv

Omar Hameed Amy L. Adams Allyson C. Baker Nicole E. Balmer

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: 30% Versus 10% Cutoff for Immunohistochemistry

2008 · Journal of Clinical Oncology · 2 citations

https://doi.org/10.1200/jco.2008.16.6868

Omar Hameed David C. Chhieng Amy L. Adams

Human epidermal growth factor receptor 2 testing in breast cancer: 30% versus 10% cutoff for immunohistochemistry.

2008 · PubMed · 1 citations

https://doi.org/10.5858/2008-132-319a-hegfrt

Omar Hameed David C. Chhieng Amy L. Adams

Research topics

topics

Pancreatic and Hepatic Oncology Research

Cervical Cancer and HPV Research

Thyroid Cancer Diagnosis and Treatment

Neuroendocrine Tumor Research Advances

Salivary Gland Tumors Diagnosis and Treatment

Chat about Author

Papers

Chat

Click to start Chat